Promoting Adherence: Strategies for Maintaining HE Therapy

Experts explore strategies for motivating treatment adherence and the importance of providers ensuring patients thoroughly understand their condition.

EP: 1.Identifying and Screening for Hepatic Encephalopathy Risk Factors

EP: 2.Achieving Post-Discharge Success: Goals in Hepatic Encephalopathy Care

EP: 3.Implementing Evidence-Based Guidelines for Hepatic Encephalopathy Management

EP: 4.Addressing the Caregiver Burden in Hepatic Encephalopathy Management

EP: 5.Optimizing Care for Newly Diagnosed Hepatic Encephalopathy

EP: 6.Enhancing Hepatic Encephalopathy Care through Pharmacist-Prescriber Collaboration

EP: 7.Managing Adverse Events Associated with HE Therapies

EP: 8.Integrating Treatment Protocols and Community Pharmacy in HE Management

Now Viewing

EP: 9.Promoting Adherence: Strategies for Maintaining HE Therapy

EP: 10.Empowering Pharmacists: Essential Insights for HE Management

EP: 11.Optimizing Transitions of Care for Hepatic Encephalopathy Patients

EP: 12.Collaborative Care: Key Stakeholders in HE Treatment and Recovery

EP: 13.Hepatic Encephalopathy: Critical Insights and Closing Thoughts

Related Videos

Related Content

Advertisement

September 5th 2024

Are OTC Proton Pump Inhibitors a Boon Or a Curse?

Madison Gill, PharmD Candidate Allyson Gill, PharmD Candidate Ajay Sharma, PhD, RPh, MPharm, PGDCR Khemraj Hirani, PhD, RPh, MBA, MPharm, RAC, CIP, CCRP

August 8th 2024

RHB-104 Plus Standard of Care Offers Extended Treatment for Crohn Disease

Kennedy Ferruggia, Assistant Editor

July 12th 2024

Heterogeneity Observed in Reporting on Drug-Drug Interactions With Proton Pump Inhibitors

Luke Halpern, Assistant Editor

June 18th 2024

Exploring the Connection Between Orange Peels, Gut Metabolism, and Heart Health

Alexandra Gerlach, Associate Editor

April 19th 2024

FDA Approves Vedolizumab for Maintenance Therapy to Treat Crohn Disease

Kennedy Ferruggia, Assistant Editor

March 26th 2024

Low Melatonin in the Gut Can Increase Risk of Neurological Disorders

Erin Hunter, Associate Editor

Related Content

Advertisement

September 5th 2024

Are OTC Proton Pump Inhibitors a Boon Or a Curse?

Madison Gill, PharmD Candidate Allyson Gill, PharmD Candidate Ajay Sharma, PhD, RPh, MPharm, PGDCR Khemraj Hirani, PhD, RPh, MBA, MPharm, RAC, CIP, CCRP

August 8th 2024

RHB-104 Plus Standard of Care Offers Extended Treatment for Crohn Disease

Kennedy Ferruggia, Assistant Editor

July 12th 2024

Heterogeneity Observed in Reporting on Drug-Drug Interactions With Proton Pump Inhibitors

Luke Halpern, Assistant Editor

June 18th 2024

Exploring the Connection Between Orange Peels, Gut Metabolism, and Heart Health

Alexandra Gerlach, Associate Editor

April 19th 2024

FDA Approves Vedolizumab for Maintenance Therapy to Treat Crohn Disease

Kennedy Ferruggia, Assistant Editor

March 26th 2024

Low Melatonin in the Gut Can Increase Risk of Neurological Disorders

Erin Hunter, Associate Editor